Intervention Review

Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin

  1. Ayeesha K Kamal1,*,
  2. Imama Naqvi1,
  3. Muhammad R Husain2,
  4. Bhojo A Khealani2

Editorial Group: Cochrane Stroke Group

Published Online: 19 JAN 2011

Assessed as up-to-date: 13 JUL 2011

DOI: 10.1002/14651858.CD008076.pub2

How to Cite

Kamal AK, Naqvi I, Husain MR, Khealani BA. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008076. DOI: 10.1002/14651858.CD008076.pub2.

Author Information

  1. 1

    Aga Khan University Hospital, Stroke Service, International Cerebrovascular Translational Clinical Research Training Program, Section of Neurology, Department of Medicine, Karachi, Pakistan

  2. 2

    Aga Khan University Hospital, Stroke Service, Section of Neurology, Department of Medicine, Karachi, Pakistan

*Ayeesha K Kamal, Stroke Service, International Cerebrovascular Translational Clinical Research Training Program, Section of Neurology, Department of Medicine, Aga Khan University Hospital, Stadium Road, PO Box 3500, Karachi, 74800, Pakistan. ayeesha.kamal@aku.edu.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 19 JAN 2011

SEARCH

  1. Current Version

    Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin

    Ayeesha K Kamal, Imama Naqvi, Muhammad R Husain and Bhojo A Khealani

    Article first published online: 19 JAN 2011 | DOI: 10.1002/14651858.CD008076.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Cilostazol versus aspirin for secondary prevention of vascular events after stroke

    Ayeesha K Kamal, Imama Naqvi, Muhammad R Husain, Bhojo A Khealani and Danish Saleheen

    Article first published online: 7 OCT 2009 | DOI: 10.1002/14651858.CD008076